BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 17496889)

  • 1. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics.
    Khidekel N; Ficarro SB; Clark PM; Bryan MC; Swaney DL; Rexach JE; Sun YE; Coon JJ; Peters EC; Hsieh-Wilson LC
    Nat Chem Biol; 2007 Jun; 3(6):339-48. PubMed ID: 17496889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tools for probing and perturbing O-GlcNAc in cells and in vivo.
    Cecioni S; Vocadlo DJ
    Curr Opin Chem Biol; 2013 Oct; 17(5):719-28. PubMed ID: 23906602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical approaches to understanding O-GlcNAc glycosylation in the brain.
    Rexach JE; Clark PM; Hsieh-Wilson LC
    Nat Chem Biol; 2008 Feb; 4(2):97-106. PubMed ID: 18202679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain.
    Khidekel N; Ficarro SB; Peters EC; Hsieh-Wilson LC
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13132-7. PubMed ID: 15340146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry.
    Skorobogatko YV; Deuso J; Adolf-Bryfogle J; Nowak MG; Gong Y; Lippa CF; Vosseller K
    Amino Acids; 2011 Mar; 40(3):765-79. PubMed ID: 20563614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A QUICk look at O-GlcNAc dynamics.
    Wells L
    Nat Chem Biol; 2007 Jun; 3(6):303-4. PubMed ID: 17510643
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel post-translational modification in nerve terminals: O-linked N-acetylglucosamine phosphorylation.
    Graham ME; Thaysen-Andersen M; Bache N; Craft GE; Larsen MR; Packer NH; Robinson PJ
    J Proteome Res; 2011 Jun; 10(6):2725-33. PubMed ID: 21500857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of O-GlcNAcylation.
    Hurtado-Guerrero R; Dorfmueller HC; van Aalten DM
    Curr Opin Struct Biol; 2008 Oct; 18(5):551-7. PubMed ID: 18822376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the Functions of O-GlcNAc Glycosylation in the Brain: The Role of Site-Specific Quantitative O-GlcNAcomics.
    Thompson JW; Sorum AW; Hsieh-Wilson LC
    Biochemistry; 2018 Jul; 57(27):4010-4018. PubMed ID: 29936833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of O-GlcNAc sites on proteins.
    Whelan SA; Hart GW
    Methods Enzymol; 2006; 415():113-33. PubMed ID: 17116471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global identification of O-GlcNAc-modified proteins.
    Nandi A; Sprung R; Barma DK; Zhao Y; Kim SC; Falck JR; Zhao Y
    Anal Chem; 2006 Jan; 78(2):452-8. PubMed ID: 16408927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tagging-via-substrate strategy for probing O-GlcNAc modified proteins.
    Sprung R; Nandi A; Chen Y; Kim SC; Barma D; Falck JR; Zhao Y
    J Proteome Res; 2005; 4(3):950-7. PubMed ID: 15952742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.
    Yuzwa SA; Yadav AK; Skorobogatko Y; Clark T; Vosseller K; Vocadlo DJ
    Amino Acids; 2011 Mar; 40(3):857-68. PubMed ID: 20706749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel strategy for global mapping of O-GlcNAc proteins and peptides using selective enzymatic deglycosylation, HILIC enrichment and mass spectrometry identification.
    Shen B; Zhang W; Shi Z; Tian F; Deng Y; Sun C; Wang G; Qin W; Qian X
    Talanta; 2017 Jul; 169():195-202. PubMed ID: 28411811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
    Whelan SA; Hart GW
    Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosolic O-glycosylation is abundant in nerve terminals.
    Cole RN; Hart GW
    J Neurochem; 2001 Dec; 79(5):1080-9. PubMed ID: 11739622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of post-translationally modified peptides of bovine alpha-crystallin using tandem mass tags and electron transfer dissociation.
    Viner RI; Zhang T; Second T; Zabrouskov V
    J Proteomics; 2009 Jul; 72(5):874-85. PubMed ID: 19245863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualization of O-GlcNAc glycosylation stoichiometry and dynamics using resolvable poly(ethylene glycol) mass tags.
    Clark PM; Rexach JE; Hsieh-Wilson LC
    Curr Protoc Chem Biol; 2013; 5(4):281-302. PubMed ID: 24391098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of O-GlcNAc glycosylation during Xenopus oocyte maturation.
    Lefebvre T; Baert F; Bodart JF; Flament S; Michalski JC; Vilain JP
    J Cell Biochem; 2004 Nov; 93(5):999-1010. PubMed ID: 15389870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does O-GlcNAc play a role in neurodegenerative diseases?
    Lefebvre T; Guinez C; Dehennaut V; Beseme-Dekeyser O; Morelle W; Michalski JC
    Expert Rev Proteomics; 2005 Apr; 2(2):265-75. PubMed ID: 15892570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.